Atlas Venture has 23 tracked deals to Benchmark's 24. Stage focus, check size, and sector fit compared side by side.
Atlas Venture is an active investor with 23 tracked deals. Benchmark is an active investor with 24 tracked deals. Benchmark shows 1 more tracked round than Atlas Venture in this dataset, which is the clearest signal of deployment pace between the two. Recent tracked names include AAVantgarde Bio and Affinia Therapeutics for Atlas Venture and Agentio and Anysphere for Benchmark.
Investors like Atlas Venture · Investors like Benchmark · Atlas Venture co-investors · Full investor directory